Literature DB >> 7517481

Modulation and intracellular transport of CD20 and CD21 antigens induced by B1 and B2 monoclonal antibodies in RAJI and JOK-1 cells--an immunofluorescence and immunoelectron microscopy study.

S Pulczynski1, A M Boesen, O M Jensen.   

Abstract

By fluorescence microscopy (FM), flow cytometry (FCM) and immunoelectron microscopy (IEM) we have shown that B1 and B2 monoclonal antibodies (MoAbs) were able to induce modulation of CD20 and CD21 in RAJI and JOK-1 cell lines. Redistribution and internalization of both antigens (Ags) after binding with MoAbs was readily demonstrated by FM, and by IEM CD20 and CD21 were found to be processed by the pathway of receptor-mediated endocytosis. The rate of intracellular transport varied: CD21 > CD20 and RAJI > JOK-1. Approximately 65 and 55% of CD20 and 60 and 45% of CD21 were cleared from the surface of RAJI and JOK-1 cells, respectively (FCM and IEM). These values, however, clearly exceeded those corresponding to internalization (11, 9, 24 and 16%) indicating shedding of Ag-MoAb complexes. No evidence of recycling was found. The present data support the hypothesis that the kinetics of modulation vary from one Ag to another and probably also reflect the stage of differentiation of the malignant B-cells. The results are discussed in the context of the possible usefulness of B1 and B2 MoAbs in the therapy of B-cell malignancies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517481     DOI: 10.1016/0145-2126(94)90092-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  7 in total

1.  Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.

Authors:  S N Karagiannis; J K Warrack; K H Jennings; P R Murdock; G Christie; K Moulder; B J Sutton; H J Gould
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.

Authors:  Kimiyasu Shiraki; Tohru Daikoku; Masaya Takemoto; Yoshihiro Yoshida; Kazuhiro Suzuki; Yasushi Akahori; Toshiomi Okuno; Yoshikazu Kurosawa; Yoshizo Asano
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  Characterization of antibody-containing vesicles shed from B-lymphoma cell lines: exposure of annexin V binding sites.

Authors:  Rosana B Michel; Mones Abu-Asab; Maria Tsokos; M Jules Mattes
Journal:  Leuk Lymphoma       Date:  2006-11

4.  Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab.

Authors:  Gregory A Rufener; Oliver W Press; Philip Olsen; Sang Yun Lee; Michael C Jensen; Ajay K Gopal; Barbara Pender; Lihua E Budde; Jeffrey K Rossow; Damian J Green; David G Maloney; Stanley R Riddell; Brian G Till
Journal:  Cancer Immunol Res       Date:  2016-04-21       Impact factor: 11.151

Review 5.  Cancer therapeutic antibodies come of age: targeting minimal residual disease.

Authors:  Tsipi Ben-Kasus; Bilha Schechter; Michael Sela; Yosef Yarden
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

6.  Chips-on-a-plate device for monitoring cellular migration in a microchannel-based intestinal follicle-associated epithelium model.

Authors:  Young Lee; Soo Jee Kim; Je-Kyun Park
Journal:  Biomicrofluidics       Date:  2019-12-24       Impact factor: 2.800

7.  High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate.

Authors:  Gladys S Ingle; Pamela Chan; J Michael Elliott; Wesley S Chang; Hartmut Koeppen; Jean-Philippe Stephan; Suzie J Scales
Journal:  Br J Haematol       Date:  2007-11-07       Impact factor: 6.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.